Patents/Assignees

Actym Therapeutics, Inc.

7 patents in portfolio

US12553047utility2026
Engineered Immunostimulatory Bacterial Strains and Uses Thereof
0 cites
US12357661utility2025
Engineered Immunostimulatory Bacterial Strains and Uses Thereof
0 cites
US12226439utility2025
Engineered Immunostimulatory Bacterial Strains and Uses Thereof
0 cites
US12201653utility2025
Engineered Immunostimulatory Bacterial Strains and Uses Thereof
0 cites
US12024709utility2024
Immunostimulatory Bacteria Engineered to Colonize Tumors, Tumor-resident Immune Cells, and the Tumor Microenvironment
0 cites
US12012600utility2024
Engineered Immunostimulatory Bacterial Strains and Uses Thereof
0 cites
US11779612utility2023
Engineered Immunostimulatory Bacterial Strains and Uses Thereof
0 cites